REGULATORY BODIES IN INDIA
In
India, the central government, via the Central Drugs Standard Control
Organization under the Ministry of Health and Family Welfare, largely works on
developing standards and regulatory measures for drugs, diagnostics and devices;
laying down regulatory measures by amending acts and rules; and regulating the
market authorization of new drugs – all in an effort to standardize clinical
research in India and bring safer drugs to the market.
CDSO Head Quarters New Delhi |
Regulatory
bodies in India involved in pharmaceutical regulation
|
||
|
Body
|
Function
|
DCGI
|
Drug Control General India
|
Regulatory apex body under
the government of India that oversees all
|
ICMR
|
Indian
Council of Medical Research
|
Apex body that formulates,
co-ordinates and promotes biomedical
|
GEAC
|
Genetic Engineering Approval Committee
|
Consists of experts in the field of
genetic engineering and molecular biology;
clinical trials involving the use of
biotech products would be
referred by DCGI to GEAC for
recommendations
|
DBT
|
Department of Biotechnology
|
Apex body that oversees the new
impetus to develop the field of modern
biology and biotechnology in India
|
AERB
|
Atomic
Energy Review Board
|
Authority that exercises
regulatory control over the approval of new types
of radiation equipment,
and for the registration/commissioning of new
radiation equipment,
inspection and decommissioning of installations
|
BARC
|
Baba Atomic Research Centre
|
Apex body that oversees and approves
all radiation related projects in India.
DCGI refers all clinical trials that
involve the use of radiopharmaceuticals
to BARC for its expert opinion
|
DCC
|
Drugs
Consultative Committee
|
Provides technical guidance to the
Central Drugs Standard Control
Organization
|
CDL
|
Central
Drugs Laboratory
|
National statutory laboratory of the
Indian government for quality control
of drugs
|
DTAB
|
Drugs
Technical Advisory Board
|
Provides technical
guidance to the CDSCO
|
No comments:
Post a Comment